Clinical Trials for Sana Biotechnology

Explore 5 clinical trials worldwide

Showing 1-5 of 5 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Sana Biotechnology

Clinical Trials (5)

NCT06294236
Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)
PHASE1Recruiting
36 participants
Started: Apr 29, 2024 · Completed: Mar 31, 2028
6 conditions1 sponsor5 locations
NCT06285422
Study Evaluating SC262 in Subjects With r/r Non-Hodgkin's Lymphoma (VIVID)
PHASE1Recruiting
35 participants
Started: Apr 18, 2024 · Completed: Mar 31, 2029
2 conditions1 sponsor3 locations
NCT06239636
First-in-human Safety Study of Hypoimmune Pancreatic Islet Transplantation in Adult Subjects With Type 1 Diabetes
EARLY_PHASE1Recruiting
2 participants
Started: Mar 8, 2024 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT05878184
Study Evaluating SC291 in Subjects With r/r B-cell Malignancies (ARDENT)
PHASE1Active, not recruiting
16 participants
Started: May 2, 2023 · Completed: Nov 4, 2038
2 conditions1 sponsor10 locations
NCT03047369
The Myelin Disorders Biorepository Project
N/ARecruiting
12,000 participants
Started: Dec 8, 2016 · Completed: Dec 8, 2030
66 conditions21 sponsors23 locations